The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
An update on molecular cat allergens: Fel d 1 and what else? Chapter 1: Fel d 1, the major cat allergen
Open accessAbstract
BACKGROUND: Cats are the major source of indoor inhalant allergens after house dust mites. The global incidence of cat allergies is rising sharply, posing a major public health problem. Ten cat allergens have been identified. The major allergen responsible for symptoms is Fel d 1, a secretoglobin and not a lipocalin, making the cat a special case among mammals. MAIN BODY: Given its clinical predominance, it is essential to have a good knowledge of this allergenic fraction, including its basic structure, to understand the new exciting diagnostic and therapeutic applications currently in development. The recent arrival of the component-resolved diagnosis, which uses molecular allergens, represents a unique opportunity to improve our understanding of the disease. Recombinant Fel d 1 is now available for in vitro diagnosis by the anti-Fel d 1 specific IgE assay. The first part of the review will seek to describe the recent advances related to Fel d 1 in terms of positive diagnosis and assessment of disease severity. In daily practice, anti-Fel d 1 IgE tend to replace those directed against the overall extract but is this attitude justified? We will look at the most recent arguments to try to answer this question. In parallel, a second revolution is taking place thanks to molecular engineering, which has allowed the development of various forms of recombinant Fel d 1 and which seeks to modify the immunomodulatory properties of the molecule and thus the clinical history of the disease via various modalities of anti-Fel d 1-specific immunotherapy. We will endeavor to give a clear and practical overview of all these trends.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig. 1 Fel d 1 crystallographic structure highlighting the location of the calcium ions. From Ligabue-Braun et al. [16] reprints in open access](https://figures.cochat.ai/paper-figures/f1741489ee2044eb8421dca5df2a443a/an-update-on-molecular-cat-allergens-fel-d-1-and-what-else-chapter-1-fel-d-1-the-figure-1.jpg)
![Fig. 2 Specific IgE levels (≥ 0.3 ISU-E) to cat allergens in children with (white box plots) or without (gray box plots) symptoms to cat at 4, 8, and 16 years of age. From Asarnoj et al. [58] reprinted with permission from the publisher](https://figures.cochat.ai/paper-figures/5abb73a14e204a51acc5d42183a2517d/an-update-on-molecular-cat-allergens-fel-d-1-and-what-else-chapter-1-fel-d-1-the-figure-2.jpg)
![Fig. 3 Difference in bronchial responsiveness (lower values show more responsiveness, a) and % difference of fraction of exhaled nitric oxide (FeNO) (b) between subjects sensitized to cat extract or both extract and components vs. subjects not sensitized to cat. Results are from a multiple linear regression model and adjusted for age, BMI, sex, smoking at baseline. Reference group are the subjects negative to both extract and any cat component. From Patelis et al. [60] reprinted with permission from the publisher](https://figures.cochat.ai/paper-figures/3408524879f5417caeedea2e858e4677/an-update-on-molecular-cat-allergens-fel-d-1-and-what-else-chapter-1-fel-d-1-the-figure-3.jpg)
![Fig. 4 Possible mechanism of immune modulation in intralymphatic immunotherapy. From Kim et al. [87] reprints in open access](https://figures.cochat.ai/paper-figures/000fe261eedc46259709d3c04c19c4a9/an-update-on-molecular-cat-allergens-fel-d-1-and-what-else-chapter-1-fel-d-1-the-figure-4.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The primary allergenic protein associated with cat allergies is Felis domesticus 1 (Fel d 1), which accounts for >95% of allergic sensitization in humans (22,23).”
From Indoor Allergen Interventions in Homes and Schools for Managing Asthma (2025) · cites this paper as [22]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Although, its role in cats remains unknown, Fel d 1 is the primary trigger for IgE-mediated allergic response in sensitive individuals (22,23).”
From Indoor Allergen Interventions in Homes and Schools for Managing Asthma (2025) · cites this paper as [22]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Sublingual immunotherapy: World Allergy Organization position paper 2013 update
Canonica, G. W., Cox, L., Pawankar, R., Baena-Cagnani, C. E., Blaiss, M., Bonini, S., Bousquet, J., Calderón, M., Compalati, E., Durham, S. R., et al. (2014) · World Allergy Organization Journal · doi:10.1186/1939-4551-7-6 · Cited by 591 · cited 1×
“Subcutaneous immunotherapy is a lengthy process requiring many administrations over a period of 3–5 years [85] and in addition entails various side effects [88].”
BackgroundDoes early exposure to cat or dog protect against later allergy development?
HESSELMAR, Åberg, Åberg, ERIKSSON, & BJÖRKSTÉN (1999) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.1999.00534.x · Cited by 540
Till, S. J., Francis, J. N., Nouri-Aria, K., & Durham, S. R. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.03.024 · Cited by 434 · cited 1×
“allergens by different delivery routes (mainly subcutaneous, sublingual or oral), results in long-term allergenic desensitization [66, 67].”
BackgroundLødrup Carlsen, K. C., Roll, S., Carlsen, K.-H., Mowinckel, P., Wijga, A. H., Brunekreef, B., Torrent, M., Roberts, G., Arshad, S. H., Kull, I., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043214 · Cited by 400 · cited 1×
“In another study, Carlsen’s team showed that the acquisition of a pet in early life did not appear to either increase or reduce the risk of asthma or allergic rhinitis symptoms in children aged 6–10 years [45].”
BackgroundTreatment of cat allergy with T-cell reactive peptides.
Norman, P. S., Ohman, J. L., Long, A. A., Creticos, P. S., Gefter, M. A., Shaked, Z., Wood, R. A., Eggleston, P. A., Hafner, K. B., Rao, P., et al. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.6.8970345 · Cited by 365 · cited 3×
“Unlike Fel d 1, these two peptides caused histamine release from basophils in < 1% of cat allergic patients and are unable to crosslink allergen-specific IgE molecules on basophils in vitro [72].”
BackgroundMethodInfluentialOldfield, W., Larché, M., & Kay, A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09332-7 · Cited by 347 · cited 1×
“were generated, in particular one using 12 shorter synthetic peptides, which reduced late-phase cutaneous reaction in a randomized double-blind controlled trial and late asthmatic reaction in another trial after 3–4 months of treatment [55, 74].”
MethodLuczynska, C. M., Li, Y., Chapman, M. D., & Platts-Mills, T. A. E. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/141.2.361 · Cited by 340
Heinzerling, L. M., Burbach, G. J., Edenharter, G., Bachert, C., Bindslev‐Jensen, C., Bonini, S., Bousquet, J., Bousquet‐Rouanet, L., Bousquet, P. J., Bresciani, M., et al. (2009) · Allergy · doi:10.1111/j.1398-9995.2009.02093.x · Cited by 332 · cited 1×
“A significant proportion of atopic subjects (about 20–40%) are sensitized to cat allergens [2, 3].”
BackgroundIntralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections
Senti, G., Crameri, R., Kuster, D., Johansen, P., Martinez-Gomez, J. M., Graf, N., Steiner, M., Hothorn, L. A., Grönlund, H., Tivig, C., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.02.026 · Cited by 271 · cited 4×
“Subcutaneous immunotherapy is a lengthy process requiring many administrations over a period of 3–5 years [85] and in addition entails various side effects [88].”
BackgroundMethodInfluential
Cited by
Atopic Dermatitis: Identification and Management of Complicating Factors
Tamagawa‐Mineoka, R., & Katoh, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082671 · Cited by 122
“The major allergen responsible for symptoms is Fel d 1, a secretoglobin [33].”
BackgroundSatyaraj, E., Wedner, H. J., & Bousquet, J. (2019) · Allergy · doi:10.1111/all.14013 · Cited by 78
“Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen).”
BackgroundComponent-resolved diagnostics in pet allergy: Current perspectives and future directions
Schoos, A. M., Nwaru, B. I., & Borres, M. P. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.12.640 · Cited by 77
van Hage, M., Käck, U., Asarnoj, A., & Konradsen, J. R. (2023) · Molecular Immunology · doi:10.1016/j.molimm.2023.03.003 · Cited by 40
Bedroom Allergen Exposure Beyond House Dust Mites
Salo, P. M., Cohn, R. D., & Zeldin, D. C. (2018) · Current Allergy and Asthma Reports · doi:10.1007/s11882-018-0805-7 · Cited by 40
Metadata
- Authors
- Bonnet, B., Messaoudi, K., Jacomet, F., Michaud, E., Fauquert, J. L., Caillaud, D., & Evrard, B.
- Affiliations
- Université Clermont Auvergne (FR)
- Centre Hospitalier Universitaire d'Angers (FR)
- Centre Hospitalier Universitaire de Poitiers (FR)
- Centre Hospitalier Universitaire de Clermont-Ferrand (FR)
- Corresponding author
- Evrard, B.
- Venue
- Allergy, Asthma & Clinical Immunology
- Published
- 2018-04-10
- Volume
- 14
- Issue
- 1
- Pages
- 14-14
- ISSN
- 1710-1484 (ISSN-L)
- 1710-1492
- PMC
- PMC5891966
- OpenAlex
- W2804582076
- Cited by
- 96
- References
- 92
- Citations by year
- 2026: 8 · 2025: 17 · 2024: 12 · 2023: 15 · 2022: 12 · 2021: 11 · 2020: 11 · 2019: 8 · 2018: 2
- FWCI
- 1.19
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- Locations
- Allergy Asthma and Clinical Immunology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Immunology and Allergy › Allergic Rhinitis and Sensitization
- Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Keywords
- Fel d 1, cat allergen, feline allergens, secretoglobin, component-resolved diagnosis, cat allergy, allergen immunotherapy, disease severity assessment, molecular allergens
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An update on molecular cat allergens: Fel d 1 and what else? Chapter 1: Fel d 1, the major cat allergen. https://app.cochat.ai/papers/10.1186/s13223-018-0239-8
- The paper
- Bonnet, B., Messaoudi, K., Jacomet, F., Michaud, E., Fauquert, J. L., Caillaud, D., & Evrard, B. (2018). An update on molecular cat allergens: Fel d 1 and what else? Chapter 1: Fel d 1, the major cat allergen. Allergy, Asthma & Clinical Immunology. https://doi.org/10.1186/s13223-018-0239-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.